Mustapha Moussaif, PhD, is an accomplished scientist with more than 24 years of experience in basic research and translational sciences in both academia and industry. In his role at the Indiana Biosciences Research Institute (IBRI), he is responsible for establishing operational platforms for small drugs and biotherapeutic antibody discovery, lead optimization and developability.
Prior to arriving at the IBRI, he worked as a scientist in the bio-therapeutics/lead engineering group with Boehringer-Ingelheim in Ridgefield, CT. Prior to that, he was a senior scientist in biotherapeutics discovery at the Icahn Medical School in Mount Sanai, NY, and worked as a research scientist at New York University in New York City. From 2004 to 2010, he was a research associate with the department of molecular pharmacology at the Albert Einstein College of Medicine in New York City.
Moussaif also served as a postdoctoral research associate in biochemistry, biophysics and molecular biology at the University of Iowa, Iowa City, IA, and as a postdoctoral fellow at Wayne State University in Detroit, MI. He has published and contributed to the publication of more than 15 research articles. For a full list of Moussaif's published research, click here.